In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

The U.S. FDA’s effort to compile a guidance for prescription, point-of-care (POC) blood glucose meter (BGM) test systems seems to show that guidances can be as iterative as the devices they govern.

Glial fibrillary acidic protein (GFAP), a blood biomarker, can be used to rapidly distinguish between hemorrhagic and ischemic stroke, according to a new prospective study. The hope, researchers say, ...

New device has the potential to help empower decentralized PCR testing in nearly 30,000 primary health centers across India, advancing efforts to improve availability of life-saving TB diagnostics ...

Please provide your email address to receive an email when new articles are posted on . A point-of-care troponin test could reduce time patients with a heart attack spend in the ED by nearly 45 ...

The point-of-care (PoC) market continues to gain traction as it is expected to reach a market valuation of US$77.8 billion by 2028 and growing at a compound annual growth rate of 9.4 per cent. PoC ...

Brad Reisfeld is a professor of chemical and biological engineering, biomedical engineering, and public health at Colorado State University. Your blood serves numerous roles to maintain your health.